Form 483

Breelyn Wilky Md Form 483, 2026-06-25

FDA issued a Form 483 to Breelyn Wilky Md on 2026-06-25 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Breelyn Wilky Md · Denver, United States · Issued June 25, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 Jun 2026
21 CFR 312.60

FD-1572, protocol compliance

Cited by Theressa B Smith

25 Jun 2026
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Theressa B Smith

25 Jun 2026
21 CFR 50.20

Consent not obtained, exceptions do not apply

Cited by Theressa B Smith

Inspected site

BWBreelyn Wilky MdDenver, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x
21 CFR 50.20Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere